We previously demonstrated that constitutive c-Abl activity was sufficient to inhibit oncogenic TGF-β signaling and its stimulation of EMT programs in normal and malignant MECs, as well as alleviate TNBC tumor development and metastasis in mice [27]. This evidence concerns the gene ABL1 and neoplasm.